Boehringer Ingelheim created a training program for their site-facing staff to better understand and anticipate the challenges facing their clinical trial sites. Patient and Site Engagement Lead, Wouter Daniëls, tells us how the program has impacted site relationships for the better. This article originally ran in September, 2025.
Lead Editorial
